pentoxifylline has been researched along with Glucose Intolerance in 2 studies
Glucose Intolerance: A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This quasi experimental study was carried out to compare the efficacy of Pentoxifylline versus Pioglitazone in non-alcoholic fatty liver disease (NAFLD) among newly detected glucose intolerant patients attended at GHPD, BIRDEM, Dhaka, Bangladesh from March 2011 to May 2012." | 7.83 | Comparative Study between Pentoxifylline and Pioglitazone in the Treatment of Non-Alcoholic Fatty Liver Disease among Newly Detected Glucose Intolerant Patients. ( Ahmed, H; Alam, MS; Chowdhury, M; Karim, MR; Paul, RK; Saha, A, 2016) |
| "This quasi experimental study was carried out to compare the efficacy of Pentoxifylline versus Pioglitazone in non-alcoholic fatty liver disease (NAFLD) among newly detected glucose intolerant patients attended at GHPD, BIRDEM, Dhaka, Bangladesh from March 2011 to May 2012." | 3.83 | Comparative Study between Pentoxifylline and Pioglitazone in the Treatment of Non-Alcoholic Fatty Liver Disease among Newly Detected Glucose Intolerant Patients. ( Ahmed, H; Alam, MS; Chowdhury, M; Karim, MR; Paul, RK; Saha, A, 2016) |
| " We hypothesized that myriocin (MYR), an inhibitor of de novo ceramide synthesis, would protect against glucose intolerance in saturated fat-fed mice, while lisofylline (LSF), a functional inhibitor of PA synthesis, would protect unsaturated fat-fed mice." | 3.76 | Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors. ( Frangioudakis, G; Garrard, J; Mitchell, TW; Nadler, JL; Raddatz, K; Schmitz-Peiffer, C, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karim, MR | 1 |
| Ahmed, H | 1 |
| Paul, RK | 1 |
| Chowdhury, M | 1 |
| Alam, MS | 1 |
| Saha, A | 1 |
| Frangioudakis, G | 1 |
| Garrard, J | 1 |
| Raddatz, K | 1 |
| Nadler, JL | 1 |
| Mitchell, TW | 1 |
| Schmitz-Peiffer, C | 1 |
2 other studies available for pentoxifylline and Glucose Intolerance
| Article | Year |
|---|---|
Comparative Study between Pentoxifylline and Pioglitazone in the Treatment of Non-Alcoholic Fatty Liver Disease among Newly Detected Glucose Intolerant Patients.
Topics: Adult; Bangladesh; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Male; Middle Aged; Non- | 2016 |
Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors.
Topics: Animals; Blood Glucose; Body Weight; Cell Line; Ceramides; Dietary Fats; Fatty Acids; Fatty Acids, M | 2010 |